See original article here PARIS and TORONTO, Jan. 4, 2018 /PRNewswire/ — Servier and Treventis announce strategic research partnership in targeting misfolded proteins implicated in neurodegenerative diseases. The collaboration covers a large drug discovery program targeting both tau and amyloïde-β (Aβ), two key proteins involved in Alzheimer’s disease. This therapeutic strategy aims to provide patients with a drug that slows…

See original Entrevestor post here Appili Therapeutics has struck an agreement to work on a vaccine that could protect people against a potential bioterror threat. The Halifax drug discovery company said Monday it signed a licence agreement with the National Research Council of Canada to help develop ATI-1701, to vaccinate against tularemia. The vaccine will…

See original CBC article here The Nova Scotia government is touting new hospital software it says can better predict breast cancer risk, but the province is not routinely sharing the results with patients or their family doctors. In October, software designed by Nova Scotia company Densitas was installed in hospitals throughout the province to automatically record…

See original ENTREVESTOR article here BlueLight Analytics Inc., a Halifax company that helps ensure the proper curing of dental fillings, has partnered with industrial giant 3M Corp. to greatly expand the startup’s sales power in the U.S. The two companies announced the partnership on Wednesday. Under the terms of the deal, 3M salespeople will offer…

CHARLOTTETOWN, Prince Edward Island (12/14/2017) – BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to manufacture Ferric Citrate, the active pharmaceutical ingredient (API) in Auryxia® tablets, a medicine approved for the treatment of two common complications of chronic kidney disease. BioVectra Inc….

See original article here DM-Density personalized breast density reporting software will be offered via vendor neutral artificial intelligence distribution platform Chicago, IL – November 26, 2017 – Advanced breast imaging analytics provider, Densitas, today announced that it now offers its automated breast density software through EnvoyAI’s scalable distribution platform to facilitate streamlined deployment of its…

See original Entrevestor Article here By Peter Moreira Halifax-based PhotoDynamic Inc. will put its plaque-killing oral health product through clinical trials in the next month, the outcome of which will shape its strategy for the next few years. The company will test its product with 20 patients at the Forsyth Institute in Boston, one of the world’s most prestigious…

See original Entrevestor article here By Peter Moreira With its indoor farm in Guelph, Ont., nearing completion, TruLeaf Sustainable Agriculture is plotting its next phase of growth with more farms, a licensing model for its technology and a new round of funding. Gregg Curwin, founder and CEO of the Halifax vertical farming company, also says the company…

2015 © Copyright - Bionova